Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick Institute and Vividion Therapeutics discovered a compound that blocks the ...
NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint mechanism distinct from PD-1/PD-L1 therapies ...
CAR2119’s single-infusion approach offers cost and compliance advantages, though its competitors maintain strong commercial ...
Autoimmune rheumatic diseases (ARDs), such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic ...
Equity Insider News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Oct. /CNW/ — Equity InsiderNews Commentary – MIT and Harvard scientists recently created engineered ...
New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...
"Everything electrical is new" on the 2027 Bolt versus its predecessor, Short said, from switches and wires to control ...
Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...
Upcoming safety data release expected to also highlight favorable tolerability profile observed to date and ease-of-use of the regimen that includes cyclophosphamide/fludarabine conditioning, and ...
Nutrition experts share the best time to take vitamin B, plus who should be supplementing, how much you need, and what all ...
This review uncovers how aging reshapes immunoglobulins, particularly IgG, IgM, and IgA, driving inflammation, cellular senescence, and tissue degeneration. By dissecting B-cell dysfunction, ...
Hominids experienced lead exposure as far back as 2-million years ago, new research finds, challenging the theory that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback